References
- Lipinski DM, Thake M, MacLaren RE. Clinical applications of retinal gene therapy. Prog Retin Eye Res [Internet]. 2013;32:22–47. Available from: http://dx.doi.org/10.1016/j.preteyeres.2012.09.001
- Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res [Internet]. 2010;29:335–375. Available from: http://linkinghub.elsevier.com/retrieve/pii/S135094621000025X
- Mauthner L. Ophthalmologische. Mittheilungen:2. Ein fall von choroideremie. Berichte des naturwissenschaftlichen-medizinischen verein innsbruck. Medical and Scientific Association Innsbruck. 1872. p. 191–197.
- Barnard AR, Groppe M, MacLaren RE. Gene therapy for choroideremia using an Adeno-Associated Viral (AAV) vector. Cold Spring Harb Perspect Med [Internet]. 2015;5:a017293. Available from: http://perspectivesinmedicine.cshlp.org/lookup/doi/10.1101/cshperspect.a017293
- Aleman TS, Han G, Serrano LW, et al. Natural history of the central structural abnormalities in choroideremia. Ophthalmology [Internet]. 2017 [cited 2016 Dec 19];124:359–373. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0161642016309071
- Hariri AH, Velaga SB, Girach A, et al. Measurement and reproducibility of preserved ellipsoid zone area and preserved retinal pigment epithelium area in eyes with choroideremia. Am J Ophthalmol [Internet]. 2017 [cited 2017 May 15];179:110–117. Available from: http://www.sciencedirect.com/science/article/pii/S0002939417301976
- Edwards TL, Groppe M, Jolly JK, et al. Correlation of retinal structure and function in choroideremia carriers. Ophthalmology [Internet]. 2015 [cited 2016 Dec 20];122:1274–1276. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25682176
- Cremers FPM, van de Pol DJR, van Kerkhoff LPM, et al. Cloning of a gene that is rearranged in patients with choroideraemia. Nature [Internet]. 1990 [cited 2017 Sep 29];347:674–677. Available from: http://www.nature.com/doifinder/10.1038/347674a0
- Andres DA, Seabra MC, Brown MS, et al. cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell. 1993;73:1091–1099.
- Wang M, Casey PJ. Protein prenylation: unique fats make their mark on biology. Nat Rev Mol Cell Biol [Internet]. 2016;17:110–122. Available from: http://www.nature.com/doifinder/10.1038/nrm.2015.11
- Xue K, Oldani M, Jolly JK, et al. Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia. Investig Opthalmology Vis Sci [Internet]. 2016 [cited 2016 Jul 18];57:3674. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.15-18364
- van den Hurk JA, Schwartz M, van Bokhoven H, et al. Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat [Internet]. 1997 [cited 2016 Oct 21];9:110–117. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9067750
- Sergeev YV, Smaoui N, Sui R, et al. The functional effect of pathogenic mutations in Rab escort protein 1. Mutat Res. 2009;665:44–50.
- Esposito G, De Falco F, Tinto N, et al. Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat. 2011;32:1460–1469.
- Torriano S, Erkilic N, Faugère V, et al. Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy. Hum Mol Genet [Internet]. 2017 [cited 2017 Sep 27];26:3573–3584. Available from: https://watermark.silverchair.com/api/watermark?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAekwggHlBgkqhkiG9w0BBwagggHWMIIB0gIBADCCAcsGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMqKI8HFVZO23euS_vAgEQgIIBnB_Khi5RddiPi-vTBXX3sp7njkWQns55xJ9JPPchkaMIQ
- Sengillo JD, Lee W, Bakhoum MF, et al. Choroideremia associated with a novel synonymous mutation in gene encoding REP-1. Retin. Cases Brief Rep. [Internet]. 2017 [cited 2017 Oct 23];1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29045269.
- Radziwon A, Arno G,K, Wheaton D, et al. Single-base substitutions in the CHM promoter as a cause of choroideremia. Hum Mutat [Internet]. 2017 [cited 2017 Jun 13];38:704–715. Available from: http://doi.wiley.com/10.1002/humu.23212
- Furgoch MJB, Mewes-Arès J, Radziwon A, et al. Molecular genetic diagnostic techniques in choroideremia. Mol Vis [Internet]. 2014;20:535–544. Available from; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4000712&tool=pmcentrez&rendertype=abstract
- Sanchez-Alcudia R, Garcia-Hoyos M, Lopez-Martinez MA, et al. A comprehensive analysis of choroideremia: from genetic characterization to clinical practice. In: Janecke AR, editor. Public Library of Science, San Francisco, California, US. PLoS One [Internet]. 2016 [cited 2017 Apr 22]. Vol. 11. p. e0151943. Available from: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0151943&type=printable
- Simunovic MP, Jolly JK, Xue K, et al. The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype. Investig Opthalmology Vis Sci [Internet]. 2016 [cited 2016 Nov 14];57:6033. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.16-20230
- Seabra MC. New insights into the pathogenesis of choroideremia: a tale of two REPs. Ophthalmic Genet [Internet]. 1996;17:43–46. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8832719
- Freund PR, Sergeev YV, MacDonald IM. Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy. Mol Genet Genomic Med [Internet]. 2016;4:344–358. Available from: http://doi.wiley.com/10.1002/mgg3.208
- Zhang FL, Casey PJ. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem. 1996;65:241–269.
- Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature [Internet]. 1990;343:425–430. Available from: http://www.nature.com/doifinder/10.1038/343425a0
- Pereira-Leal JB, Hume AN, Seabra MC. Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease. FEBS Lett [Internet]. 2001;498:197–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11412856
- Roosing S, Collin RWJ, den Hollander AI, et al. Prenylation defects in inherited retinal diseases. J Med Genet [Internet]. 2014;51:143–151. Available from; http://www.ncbi.nlm.nih.gov/pubmed/24401286
- Seabra MC, Wasmeier C. Controlling the location and activation of Rab GTPases. Curr Opin Cell Biol [Internet]. 2004 [cited 2017 Oct 25];16:451–457. Available from: https://ac.els-cdn.com/S0955067404000833/1-s2.0-S0955067404000833-main.pdf?_tid=eb521912-b98f-11e7-a93e-00000aacb35d&acdnat=1508941524_7bd4bfc020735db2625aedcf7cc0974d
- Seabra MC, Mules EH, Hume AN. Rab GTPases, intracellular traffic and disease. Trends Mol Med [Internet]. 2002;8:23–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11796263
- Seabra MC, Goldstein JL, Südhof TC, et al. Rab geranylgeranyl transferase. A multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or Cys-Cys. J Biol Chem [Internet]. 1992 [cited 2017 Oct 24];267:14497–14503. Available from: http://www.jbc.org/content/267/20/14497.full.pdf
- Seabra MC, Brown MS, Slaughter CA, et al. Purification of component A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene product. Cell. 1992;70:1049–1057.
- Seabra MC, Brown MS, Goldstein JL. Retinal degeneration in choroideremia: deficiency of Rab geranylgeranyl transferase. Science [Internet]. 1993 [cited 2017 Feb 20];259:377–381. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8380507.
- Cremers FPM, Molloy CM, van de Pol DJR, et al. An autosomal homologue of the choroideremia gene colocalizes with the usher syndrome type II locus on the distal part of chromosome 1q. Hum Mol Genet [Internet]. 1992 [cited 2017 Oct 24];1:71–75. Available from: https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/hmg/1/2/10.1093/hmg/1.2.71/2/1-2-71.pdf?Expires=1508938487&Signature=D7JEVXa52rdnxBN~rr3c0Kz3Qt6~E0G75vT9ons1sK1zxCeJJk01~TFgLEpRp51BBb4ajeLaY5pwO~Au5Xcg9Goqngsz7lNTIL7zQCVf7kbr2hx9~YTF~y
- Cremers FPM, Armstrong SA, Seabra MC, et al. REP-2, a Rab escort protein encoded by the choroideremia-like gene. J Biol Chem [Internet]. 1994;269:2111–2117. Available from; http://www.ncbi.nlm.nih.gov/pubmed/8294464
- Alexandrov K, Horiuchi H, Steele-Mortimer O, et al. Rab escort protein-1 is a multifunctional protein that accompanies newly prenylated Rab proteins to their target membranes. EMBO J [Internet]. 1994;13:5262–5273. Available from; http://www.ncbi.nlm.nih.gov/pubmed/7957092
- Seabra MC, Ho YK, Anant JS. Deficient geranylgeranylation of Ram/Rab27 in choroideremia. J Biol Chem. 1995;270:24420–24427.
- Chen D, Guo J, Miki T, et al. Molecular cloning and characterization of Rab27a and Rab27b, novel human Rab proteins shared by melanocytes and platelets. Biochem Mol Med [Internet]. 1997 [cited 2017 Oct 26];60:27–37. Available from: https://ac.els-cdn.com/S1077315096925594/1-s2.0-S1077315096925594-main.pdf?_tid=83574584-ba30-11e7-896a-00000aacb361&acdnat=1509010500_956c6fb75d67bdf28ec2e2e9926410c3
- Wilson SM, Yip R, Swing DA, et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci U S A [Internet]. 2000 [cited 2017 Oct 26];97:7933–7938. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10859366
- Hume AN, Collinson LM, Rapak A, et al. Rab27a regulates the peripheral distribution of melanosomes in. Melanocytes J Cell Biol [Internet]. 2001 [cited 2017 Oct 25];152:795–808. Available from: http://www.jcb.org/cgi/content/full/152/4/795
- Bahadoran P, Aberdam E, Mantoux F, et al. Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol [Internet]. 2001 [cited 2017 Oct 25];152:843–850. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11266474
- Futter CE, Ramalho JS, Jaissle GB, et al. The role of Rab27a in the regulation of melanosome distribution within retinal pigment epithelial cells. Mol Biol Cell [Internet]. 2004 [cited 2017 Oct 25];15:2264–2275. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14978221
- Lopes VS, Ramalho JS, Owen DM, et al. The ternary Rab27a-myrip-myosin VIIa complex regulates melanosome motility in the retinal pigment epithelium. Traffic [Internet]. 2007 [cited 2017 Oct 26];(8):486–499. Available from: http://doi.wiley.com/10.1111/j.1600-0854.2007.00548.x.
- Lopes VS, Wasmeier C, Seabra MC, et al. Melanosome maturation defect in Rab38-deficient retinal pigment epithelium results in instability of immature melanosomes during transient melanogenesis. Mol Biol Cell [Internet]. 2007 [cited 2017 Oct 26];18:3914–3927. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17671165
- Larijani B, Hume AN, Tarafder AK, et al. Multiple factors contribute to inefficient prenylation of Rab27a in Rab Prenylation diseases. J Biol Chem [Internet]. 2003 [cited 2017 Feb 20];278:46798–46804. Available from: http://www.jbc.org/lookup/doi/10.1074/jbc.M307799200
- Rak A, Pylypenko O, Niculae A, et al. Structure of the Rab7: REP-1Complex. Cell [Internet]. 2004;117:749–760. Available from; http://linkinghub.elsevier.com/retrieve/pii/S0092867404004970
- Köhnke M, Delon C, Hastie ML, et al. Rab GTPase prenylation hierarchy and its potential role in choroideremia disease. PLoS One. 2013;8:1–11.
- van den Hurk JA, Hendriks W, van de Pol DJ, et al. Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Hum Mol Genet [Internet]. 1997 [cited 2017 Apr 22];6:851–858. Available from: https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/hmg/6/6/10.1093_hmg_6.6.851/3/6-6-851.pdf?Expires=1509104435&Signature=CVBE0DqFJPtoc1YPOTWBrPKnkyXaH3-jr8ciW6la08vRHLdfE9I0TH668Qp5RttvBzG-cttcxP~vlU8tAEOUW2IBio6-mwHg199prC0URPgx8DHmvmDT
- Tolmachova T. Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest [Internet]. 2006;116:386–394. Available from: http://www.jci.org/cgi/doi/10.1172/JCI26617
- Tolmachova T, Wavre-Shapton ST, Barnard AR, et al. Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type–specific knockout mouse models of choroideremia. Investig Opthalmology Vis Sci [Internet]. 2010 [cited 2017 Oct 27];51:4913. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.09-4892
- Wavre-Shapton ST, Tolmachova T, Lopes Da Silva M, et al. Conditional ablation of the choroideremia gene causes age-related changes in mouse retinal pigment epithelium. PLoS One [Internet]. 2013 [cited 2013 Oct 1];8:e57769. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3584022&tool=pmcentrez&rendertype=abstract
- Detter JC, Zhang Q, Mules EH, et al. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci U S A [Internet]. 2000 [cited 2017 Oct 26];97:4144–4149. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10737774
- Starr CJ, Kappler JA, Chan DK, et al. Mutation of the zebrafish choroideremia gene encoding Rab escort protein 1 devastates hair cells. Proc Natl Acad Sci U S A [Internet]. 2004 [cited 2017 Oct 27];101:2572–2577. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14983050
- Krock BL, Bilotta J, Perkins BD. Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia. Proc Natl Acad Sci [Internet]. 2007 [cited 2017 Oct 27];104:4600–4605. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1810335/pdf/zpq4600.pdf
- Moosajee M, Tulloch M, Baron RA, et al. Single choroideremia gene in nonmammalian vertebrates explains early embryonic lethality of the zebrafish model of choroideremia. Investig Opthalmology Vis Sci [Internet]. 2009 [cited 2017 Oct 27];50:3009. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.08-2755
- Richardson R, Tracey-White D, Webster A, et al. The zebrafish eye – a paradigm for investigating human ocular genetics. Eye [Internet]. 2017 [cited 2017 Jan 12];31:68–86. Available from: http://www.nature.com/articles/eye2016198
- MacDonald I, Mah DY, Ho YK, et al. A practical diagnostic test for choroideremia. Ophthalmology [Internet]. 1998 [cited 2017 Oct 31];105:1637–1640. Available from: https://ac.els-cdn.com/S0161642098990315/1-s2.0-S0161642098990315-main.pdf?_tid=27608950-be4c-11e7-84c6-00000aab0f6b&acdnat=1509462174_0f0b72a2d70c01c1a5e511c06bdac571
- McTaggart KE, Tran M, Mah DY, et al. Mutational analysis of patients with the diagnosis of choroideremia. Hum Mutat [Internet]. 2002 [cited 2017 Oct 31];20:189–196. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12203991
- Moosajee M, Tracey-White D, Smart M, et al. Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model. Hum Mol Genet [Internet]. 2016 [cited 2017 Sep 29];25:3416–3431. Available from: https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/ddw184
- Vasireddy V, Mills JA, Gaddameedi R, et al. AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. In: Lewin A, editor. PLoS One [Internet]. Public Library of Science, San Francisco, California, US. 2013. Vol. 8. p. e61396. Available from: http://dx.plos.org/10.1371/journal.pone.0061396
- Edwards TL, Williams J, Patrício MI, et al. Novel non-contiguous exon duplication in choroideremia. Clin Genet [Internet]. 2017 [cited 2017 Oct 31]:1–5. Available from: http://doi.wiley.com/10.1111/cge.13021
- Anand V, Barral DC, Zeng Y, et al. Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus. Vis Res [Internet]. 2003 [cited 2017 Jul 11];43:919–926. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0042698902003899
- Strunnikova NV, Barb J, Sergeev YV, et al. Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients. PLoS One [Internet]. 2009 [cited 2012 Apr 18];4:e8402. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2793004&tool=pmcentrez&rendertype=abstract
- Tolmachova T, Tolmachov OE, Tracey-White D, et al. CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice. J Gene Med. Wiley, West Sussex, UK. 2012;158–168.
- Cereso N, Pequignot MO, Robert L, et al. Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient. Mol Ther Methods Clin Dev [Internet]. 2014;1:14011. Available from; http://www.nature.com/articles/mtm201411
- Gordiyenko NV, Fariss RN, Zhi C, et al. Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium. Invest Ophthalmol Vis Sci [Internet]. 2010 [cited 2012 May 31];51:1143–1150. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2868448&tool=pmcentrez&rendertype=abstract
- Zhang AY, Mysore N, Vali H, et al. Choroideremia is a systemic disease with lymphocyte crystals and plasma lipid and Rbc membrane abnormalities. Investig Opthalmology Vis Sci [Internet]. 2015;56:8158. Available from; http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.14-15751
- Nanda A, Salvetti AP, Martinez-Fernandez De La Camara C, et al. Misdiagnosis of X-linked retinitis pigmentosa in a choroideremia patient with heavily pigmented fundi. Ophthalmic Genet. [Internet]. 2018 [cited 2018 Feb 5];1–4. Available from: https://www.tandfonline.com/doi/full/10.1080/13816810.2018.1430242.
- Moore NA, Morral N, Ciulla TA, et al. Gene therapy for inherited retinal and optic nerve degenerations. Expert Opin. Biol. Ther. [Internet]. 2017 [cited 2017 Nov 16];1–13. Available from: https://www.tandfonline.com/doi/full/10.1080/14712598.2018.1389886.
- MacLaren RE. Gene therapy for retinal disease: what lies ahead. Ophthalmologica [Internet]. 2015 [cited 2016 Aug 2];234:1–5. Available from: http://www.karger.com/?doi=10.1159/000438872
- Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med [Internet]. 2008 [cited 2016 Aug 24];358:2231–2239. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa0802268
- Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to rpe65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19:979–990.
- Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med. 2008;358(21):2240–2248.
- Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Neurobiology. 1999;96:9920–9925.
- Jacobson SG, Acland GM, Aguirre GD, et al. Safety of recombinant adeno-associated virus type 2–RPE65 vector delivered by ocular subretinal injection. Mol Ther. 2006;13:1074–1084.
- Cideciyan AV, Jacobson SG, Beltran WA, et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci [Internet]. 2013;110:E517–E525. Available from; http://www.pnas.org/cgi/doi/10.1073/pnas.1218933110
- Bainbridge JWB, Mehat MS, Sundaram V, et al. Long-term effect of gene therapy on Leber’s congenital amaurosis. N Engl J Med [Internet]. 2015;372:1887–1897. Available from; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4497809&tool=pmcentrez&rendertype=abstract
- Testa F, Maguire AM, Rossi S, et al. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2. Ophthalmology [Internet]. 2013 [cited 2017 Nov 17];120:1283–1291. Available from: https://ac.els-cdn.com/S0161642012011682/1-s2.0-S0161642012011682-main.pdf?_tid=738d0458-cbac-11e7-a916-00000aab0f01&acdnat=1510932900_1696165c42e0a0626f36c9189b1e63f5
- Bennett J, Wellman J, Marshall KA, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet [Internet]. 2016 [cited 2016 Jul 12];388:661–672. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673616303713
- Kaplitt MG, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial. Lancet. 2007;369:2097–2105.
- Patrício MI, Barnard AR, Orlans HO, et al. Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina. Mol Ther Nucleic Acids [Internet]. 2017 [cited 2017 Mar 3];6:198–208. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2162253116303742
- Tolmachova T, Tolmachov OE, Barnard AR, et al. Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo. J Mol Med (Berl). 2013;91:825–837.
- MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet [Internet]. 2014;383:1129–1137. Available from: http://dx.doi.org/10.1016/S0140-6736(13)62117-0
- Edwards TL, Jolly JK, Groppe M, et al. Visual acuity after retinal gene therapy for choroideremia. N Engl J Med [Internet]. 2016 [cited 2016 Apr 28];374:1996–1998. Available from: http://www.nejm.org/doi/full/10.1056/NEJMc1509501
- Fischer MD, Hickey DG, Singh MS, et al. Evaluation of an optimized injection system for retinal gene therapy in human patients. Hum Gene Ther Methods [Internet]. 2016 [cited 2018 Feb 2];27:150–158. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27480111
- Xue K, Groppe M, Salvetti AP, et al. Technique of retinal gene therapy: delivery of viral vector into the subretinal space. Eye [Internet]. 2017 [cited 2017 Aug 21];31:1308–1316. Available from: https://www.nature.com/eye/journal/vaop/ncurrent/pdf/eye2017158a.pdf
- Re M, Xue K, Jolly JK, et al. Retinal gene therapy for choroideremia in a multicentre dose escalation phase I/II clinical trial. ARVO Annu Meet. 2018;e–Abstract.
- Lam BL, Verriotto J, Gregori N, et al. Choroideremia gene therapy phase II clinical trial: 6-month results. Invest Ophthalmol Vis Sci [Internet]. 2017;58:3386. Available from; http://dx.doi.org/
- Moosajee M, Ramsden SC, Black GC, et al. Clinical utility gene card for: choroideremia. Eur J Hum Genet [Internet]. 2014 [cited 2016 Oct 27];22. Available from: http://www.nature.com/doifinder/10.1038/ejhg.2013.183
- Welch EM, Barton ER, Zhuo J, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature [Internet]. 2007 [cited 2017 Nov 23];447:87–91. Available from: https://www.nature.com/articles/nature05756.pdf
- Moosajee M, Gregory-Evans K, Ellis CD, et al. Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet [Internet]. 2008 [cited 2017 Sep 29];17:3987–4000. Available from: https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/ddn302
- Schwarz N, Carr A-J, Lane A, et al. Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet [Internet]. 2015 [cited 2017 Nov 10];24:972–986. Available from: https://watermark.silverchair.com/ddu509.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAa4wggGqBgkqhkiG9w0BBwagggGbMIIBlwIBADCCAZAGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMe7PJU-xA0GUp2mu0AgEQgIIBYTDlMVR2El9Rr5IBGCKLFCfBKVdwEwoquj3cFUuQNpayOfzP
- Ramsden CM, Nommiste BR, Lane A, et al. Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs. Sci Rep [Internet]. 2017 [cited 2017 Oct 12];7:51. Available from: http://www.nature.com/articles/s41598-017-00142-7
- Einav S, Glenn JS. Prenylation inhibitors: a novel class of antiviral agents. J Antimicrob Chemother [Internet]. 2003 [cited 2017 Nov 23];52:883–886. Available from: https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/dkg490
- Ali BR, Nouvel I, Leung KF, et al. A novel statin-mediated “prenylation block-and-release” assay provides insight into the membrane targeting mechanisms of small GTPases. Biochem Biophys Res Commun [Internet]. 2010 [cited 2017 Dec 5];397:34–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20471365
- Abstracts of the 50th ISCEV (International Society for Clinical Electrophysiology of Vision) International Symposium. Doc. Ophthalmol. [Internet]. 2012 June 3–7. Valencia, Spain. [cited 2017 Dec 6];124:3–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22678507.
- Zhou Q, Weis E, Ye M, et al. An internet-based health survey on the co-morbidities of choroideremia patients. Ophthalmic Physiol Opt [Internet]. 2013 [cited 2017 Dec 5];33:157–163. Available from: http://doi.wiley.com/10.1111/opo.12023
- Futter CE. The molecular regulation of organelle transport in mammalian retinal pigment epithelial cells. Pigment Cell Res [Internet]. 2006 [cited 2012 May 31];19:104–111. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16524426
- Alory C, Balch WE. Organization of the Rab-GDI/CHM superfamily: the functional basis for choroideremia disease. Traffic [Internet]. 2001 [cited 2017 Oct 30];2:532–543. Available from: http://doi.wiley.com/10.1034/j.1600-0854.2001.20803.x
- Schraermeyer U, Kopitz J, Peters S, et al. Tyrosinase biosynthesis in adult mammalian retinal pigment epithelial cells. Exp Eye Res [Internet]. 2006 [cited 2018 Jan 30];83:315–321. Available from: https://ac.els-cdn.com/S0014483506001369/1-s2.0-S0014483506001369-main.pdf?_tid=48acb292-05c2-11e8-a551-00000aab0f6c&acdnat=1517319443_731315fc58db244cc68f2f338cf7a74b
- Patwardhan A, Bardin S, Miserey-Lenkei S, et al. Routing of the RAB6 secretory pathway towards the lysosome related organelle of melanocytes. Nat Commun [Internet]. 2017 [cited 2017 Jun 15];8:15835. Available from: https://www.nature.com/articles/ncomms15835.pdf?proof=true
- Biesemeier A, Kreppel F, Kochanek S, et al. The classical pathway of melanogenesis is not essential for melanin synthesis in the adult retinal pigment epithelium. Cell Tissue Res [Internet]. 2010 [cited 2018 Jan 31];339:551–560. Available from: http://link.springer.com/10.1007/s00441-009-0920-9
- Aylward J, Xue K, Patrício M, et al. Retinal degeneration in choroideremia follows an exponential decay function. In Ophthalmology. Ophthalmology journal. From the American Academic of Ophthalmology. San Francisco, California, US. 2018. https://doi.org/10.1016/j.ophtha.2018.02.004
- Russell S, Bennett J, Wellman JA, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet [Internet]. 2017 [cited 2017 Nov 20];390:849–860. Available from: https://ac.els-cdn.com/S0140673617318688/1-s2.0-S0140673617318688-main.pdf?_tid=bd3eea54-cdf9-11e7-b9cc-00000aab0f01&acdnat=1511185996_c6d07a5bf76efdbdb0c22488ce57797d